Meet 6 Aussie biotech startups vying to be the next CSL
A profile of six life-science ventures that graduated from Melbourne bioincubator Jumar's debut program, one of which, Tessara Therapeutics, won a $3 million research grant in December.
Startup
Nebuliser mask for respiratory diseases
Melbourne, VIC
Every investor coverage indicates participated in a round Misti raised.
| Investor | Rounds | Invested |
|---|---|---|
| Jumar Bioincubator | Accelerator | - |
| Startmate | Accelerator | - |
Investors whose own portfolio pages list Misti, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Boson Ventures | its portfolio page ↗ |
Companies Misti acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Misti. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A profile of six life-science ventures that graduated from Melbourne bioincubator Jumar's debut program, one of which, Tessara Therapeutics, won a $3 million research grant in December.
ANDHealth and LaunchVic announced the 2024 ACTIVATE accelerator cohort, selecting fifteen Victorian digital health startups for a six-month program focused on commercialisation and investment readiness.
Startup Daily covers Startmate's Winter 2023 accelerator intake of 13 startups, the accelerator's reported fund performance, its backer returns, and an upcoming Demo Day alongside SXSW Sydney.